81
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole

, , , , , , , , , & show all
Pages 719-722 | Published online: 24 Feb 2021

References

  • Randolph C, Kaplan C, Fraser B. Rapid desensitization to Fluconazole (Diflucan). Ann Allergy Asthma Immunol. 2008;100(6):616–617. doi:10.1016/S1081-1206(10)60063-418592829
  • Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006;20(3):507–544.16984867
  • Medaris LA, Ponce B, Hyde Z, et al. Cryptococcal osteomyelitis: a report of 5 cases and a review of the recent literature. Mycoses. 2016;59(6):334–342.26968335
  • Wood L, Miedzinski L. Skeletal cryptococcosis: case report and review of the literature. Can J Infect Dis. 1996;7:125–132.22514429
  • Zhou HX, Lu L, Chu T, et al. Skeletal cryptococcosis from 1977 to 2013. Front Microbiol. 2015;5:740.25642211
  • Ahn JH, Park C, Lee CW, Kim YC. Cryptococcal osteomyelitis of the first metatarsal head in an immunocompetent patient. J Am Pediatr Med Assoc. 2017;107(3):248–252.
  • Sang J, Yang Y, Fan Y, et al. Isolated iliac cryptococcosis in an immunocompetent patient. PLoS Negl Trop Dis. 2018;12(3):e0006206.29596420
  • Li Z, Liang J, Shen J, Qiu G, Weng X. Thoracolumbar scoliosis due to cryptococcal osteomyelitis: a case report and review of the literature. Medicine. 2016;95(5):e2613.26844472
  • Jarvis JN, Leeme TB, Mooketsi M, et al. Short-course high-dose liposomal amphotericin b for human immunodeficiency virus–associated cryptococcal meningitis: a phase 2 randomized controlled trial. Clin Infect Dis. 2019;68(3):393–401.29945252
  • Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50(3):291–322.20047480
  • Molloy SF, Kanyama C, Heyderman RS, et al. Antifungal combinations for treatment of cryptococcal meningitis in Africa. N Engl J Med. 2018;378(11):1004–1017.29539274
  • Chesdachai S, Rajasingham R, Nicol MR, et al. Minimum inhibitory concentration distribution of fluconazole against cryptococcus species and the fluconazole exposure prediction model. Open Forum Infect Dis. 2019;6(10):ofz369.31420668